UNSPSC 51352310: Estrazinol

This classification denotes a selective estrogen receptor modulator with the molecular formula C20H25NO2, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 9KLU2E3573. The term ESTRAZINOL ACETONIDE is an International Non-Proprietary Name or INN. European Medicines Agency schedules estrazinol in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB07248MIG. Most nations schedule estrazinol under HS 29372300 and SITC 54153. As of Q4 2014, ESTRAZINOL remains the US FDA Preferred Term for this commodity.

Estrazinol bears US NLM identifiers UMLS ID C2348469 and NCI Concept Code C72767. SMILES: CC12CCC3C4=C(CCN3C1CCC2(C#C)O)C=C(C=C4)OC.

UNSPSC 51352310 Estrazinol is a Commodity code for a synthetic estrogen pharmaceutical used in hormone replacement therapy and other clinical applications. State and local governments procure this product primarily through state health departments, county public health agencies, and corrections systems serving incarcerated populations requiring hormone therapy. The product appears in solicitations as either a branded or generic pharmaceutical line item within broader drug procurement or formulary management contracts, where issuing bodies specify quantity, dosage form (typically tablets or oral suspension), and delivery schedules tied to patient census or clinical demand.

Recent opportunities under this code are sparse. No posted state or local RFP, RFQ, IFB, or ITB records were identified in the available data, limiting visibility into current geographic concentration, repeat buyers, or representative response dates. Pharmaceutical procurement at the state and local level often flows through standing state contracts, master price agreements, or cooperative purchasing vehicles (such as state health department group purchasing agreements) rather than individual open solicitations, which may reduce the visibility of estrazinol-specific buys in public notice databases. Firms pursuing this code should monitor state health department pharmaceutical solicitations, corrections-agency medical supply RFPs, and cooperative purchasing catalogs in high-population states and those with large prison healthcare systems.